Staying innovative in a growing business
Dentisan [Quadralene] is delighted to announce that Managing Director Andy Corley, has been invited to take part in the CBI’s MSB (Medium Sized Business) Summit 2016, entitled ‘Meeting the Productivity Challenge’.
This prestigious event, being held on 7 July in Central London, will explore the challenges that medium-sized businesses face in raising productivity and highlight some of the practical steps that such businesses can take to increase output and unlock new growth.
Designed for CEOs and senior leaders of MSBs, the Summit will include keynote and panel sessions and Andy will participate in one of the key case studies ‘Staying innovative in a growing business’.
Whilst companies such as Dentisan [Quadralene] have a proud legacy of developing new and exciting technologies and innovations, the UK as a whole underperforms when investing in Research & Development. Addressing this issue is essential for international competitiveness and plays a crucial role in making the UK a place in which to invest and grow a business. During the session Andy will highlight the steps Dentisan [Quadralene] has taken to become an innovator within its market, and explain the important role that R&D has played in its success.
Andy commented, “I am delighted to be taking part in such an important event. Innovation is central to our business ethos, and we could not succeed without significant investment in R&D. It has been a lynchpin of our business, and concentrating on innovation has helped us to both attract new employees and release the latent potential within our existing team. I am very much looking forward to sharing our experiences with other like-minded business leaders.”
For more information, visit www.dentisan.co.uk
Twitter: @DentisanLtd
Facebook: Dentisan Ltd
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.